Mesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients

Conditions:   Diabetes Mellitus;   Diabetes Mellitus, Type 1;   Diabetes Mellitus, Insulin-Dependent Interventions:   Biological: Intravenous Injection of autologous mesenchymal stem cells;   Other: Intravenous injection of placebo Sponsors:   Royan Institute;   Tehran University of Medical Sciences;   Iranian Stem Cell Council Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials